Validation of diacylglycerolacyltransferase I as a novel target for the treatment of obesity and dyslipidemia using a potent and selective small molecule inhibitor
Read More Digital Compounding Prescriptions in 2025: What Physicians Need to Know About Access, Safety, and Cost Transparency Executive summary Compounded medications continue to play an important role in patient care when FDA-approved products are unavailable, contraindicated, or insufficient for individualized needs
For detailed information on compounded formulation shelf life, see our guide on compounded tirzepatide expiration dates
Importantly, not everyone needs to reach the maximum tirzepatide dose to lose weight
Lepodisiran, an extended-duration short interfering RNA targeting lipoprotein(a): a randomized dose-ascending clinical trial
Compliance / Safety FOR RESEARCH USE ONLY